|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Scotlandi K, Picci P and Kovar H: Targeted
therapies in bone sarcomas. Curr Cancer Drug Targets. 9:843–853.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Lønning PE and Knappskog S: Mapping
genetic alterations causing chemoresistance in cancer: Identifying
the roads by tracking the drivers. Oncogene. 32:5315–5330. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Derdak Z, Mark NM, Beldi G, Robson SC,
Wands JR and Baffy G: The mitochondrial uncoupling protein-2
promotes chemoresistance in cancer cells. Cancer Res. 68:2813–2819.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Yamamoto S, Tsuda H, Honda K, Onozato K,
Takano M, Tamai S, Imoto I, Inazawa J, Yamada T and Matsubara O:
Actinin-4 gene amplification in ovarian cancer: A candidate
oncogene associated with poor patient prognosis and tumor
chemoresistance. Mod Pathol. 22:499–507. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zhang W, Li Q, Song C and Lao L: Knockdown
of autophagy- related protein 6, Beclin-1, decreases cell growth,
invasion, and metastasis and has a positive effect on
chemotherapy-induced cytotoxicity in osteosarcoma cells. Tumour
Biol. 36:2531–2539. 2014. View Article : Google Scholar
|
|
7
|
Zhang Y, Duan G and Feng S: MicroRNA-301a
modulates doxorubicin resistance in osteosarcoma cells by targeting
AMP-activated protein kinase alpha 1. Biochem Biophys Res Commun.
459:367–373. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhao Z, Zhang L, Yao Q and Tao Z: miR-15b
regulates cisplatin resistance and metastasis by targeting PEBP4 in
human lung adenocarcinoma cells. Cancer Gene Ther. 22:108–114.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhao Y, Zhao L, Ischenko I, Bao Q, Schwarz
B, Nieß H, Wang Y, Renner A, Mysliwietz J, Jauch KW, et al:
Antisense inhibition of microRNA-21 and microRNA-221 in
tumor-initiating stem-like cells modulates tumorigenesis,
metastasis, and chemotherapy resistance in pancreatic cancer.
Target Oncol. Feb 3–2015.Epub ahead of print. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lian F, Cui Y, Zhou C, Gao K and Wu L:
Identification of a plasma four-microRNA panel as potential
noninvasive biomarker for osteosarcoma. PLoS One. 10:e01214992015.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Luo XJ, Tang DG, Gao TL, Zhang YL, Wang M,
Quan ZX and Chen J: MicroRNA-212 inhibits osteosarcoma cells
proliferation and invasion by down-regulation of Sox4. Cell Physiol
Biochem. 34:2180–2188. 2014. View Article : Google Scholar
|
|
12
|
Nata T, Fujiya M, Ueno N, Moriichi K,
Konishi H, Tanabe H, Ohtake T, Ikuta K and Kohgo Y: MicroRNA-146b
improves intestinal injury in mouse colitis by activating nuclear
factor-κB and improving epithelial barrier function. J Gene Med.
15:249–260. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
13
|
Deng X, Wu B, Xiao K, Kang J, Xie J, Zhang
X and Fan Y: MiR-146b-5p promotes metastasis and induces
epithelial-mesenchymal transition in thyroid cancer by targeting
ZNRF3. Cell Physiol Biochem. 35:71–82. 2015. View Article : Google Scholar
|
|
14
|
Wu PY, Zhang XD, Zhu J, Guo XY and Wang
JF: Low expression of microRNA-146b-5p and microRNA-320d predicts
poor outcome of large B-cell lymphoma treated with
cyclophospha-mide, doxorubicin, vincristine, and prednisone. Hum
Pathol. 45:1664–1673. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Dieudonné FX, Marion A, Marie PJ and
Modrowski D: Targeted inhibition of T-cell factor activity promotes
syndecan-2 expression and sensitization to doxorubicin in
osteosarcoma cells and bone tumors in mice. J Bone Miner Res.
27:2118–2129. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kreslova J, Machon O, Ruzickova J, Lachova
J, Wawrousek EF, Kemler R, Krauss S, Piatigorsky J and Kozmik Z:
Abnormal lens morphogenesis and ectopic lens formation in the
absence of beta-catenin function. Genesis. 45:157–168. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Machon O, Kreslova J, Ruzickova J, Vacik
T, Klimova L, Fujimura N, Lachova J and Kozmik Z: Lens
morphogenesis is dependent on Pax6-mediated inhibition of the
canonical Wnt/beta-catenin signaling in the lens surface ectoderm.
Genesis. 48:86–95. 2010.
|
|
18
|
Jiang X, Hao HX, Growney JD, Woolfenden S,
Bottiglio C, Ng N, Lu B, Hsieh MH, Bagdasarian L, Meyer R, et al:
Inactivating mutations of RNF43 confer Wnt dependency in pancreatic
ductal adenocarcinoma. Proc Natl Acad Sci USA. 110:12649–12654.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ryland GL, Hunter SM, Doyle MA, Rowley SM,
Christie M, Allan PE, Bowtell DD and Gorringe KL; Campbell IG;
Australian Ovarian Cancer Study Group: RNF43 is a tumour suppressor
gene mutated in mucinous tumours of the ovary. J Pathol.
229:469–476. 2013. View Article : Google Scholar
|
|
20
|
Zhou X, Yuan B, Yuan W, Wang C, Gao R and
Wang J: The expression and clinical significance of high mobility
group nucleosome binding domain 5 in human osteosarcoma. Tumour
Biol. 35:6539–6547. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Lin F, Wang X, Jie Z, Hong X, Li X, Wang M
and Yu Y: Inhibitory effects of miR-146b-5p on cell migration and
invasion of pancreatic cancer by targeting MMP16. J Huazhong Univ
Sci Technolog Med Sci. 31:509–514. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhao Z, Tao L, Shen C, Liu B, Yang Z and
Tao H: Silencing of Barkor/ATG14 sensitizes osteosarcoma cells to
cisplatin-induced apoptosis. Int J Mol Med. 33:271–276. 2014.
|
|
23
|
Wang J, Shi Q, Yuan TX, Song QL, Zhang Y,
Wei Q, Zhou L, Luo J, Zuo G, Tang M, et al: Matrix
metalloproteinase 9 (MMP-9) in osteosarcoma: Review and
meta-analysis. Clin Chim Acta. 433:225–231. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Shang HS, Chang JB, Lin JH, Lin JP, Hsu
SC, Liu CM, Liu JY, Wu PP, Lu HF, Au MK, et al: Deguelin inhibits
the migration and invasion of U-2 OS human osteosarcoma cells via
the inhibition of matrix metalloproteinase-2/-9 in vitro.
Molecules. 19:16588–16608. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Li Y, Wang Y, Yu L, Sun C, Cheng D, Yu S,
Wang Q, Yan Y, Kang C, Jin S, et al: miR-146b-5p inhibits glioma
migration and invasion by targeting MMP16. Cancer Lett.
339:260–269. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Aguilera Ó, González-Sancho JM, Zazo S,
Rincón R, Fernández AF, Tapia O, Canals F, Morte B, Calvanese V,
Orgaz JL, et al: Nuclear DICKKOPF-1 as a biomarker of
chemoresistance and poor clinical outcome in colorectal cancer.
Oncotarget. 6:5903–5917. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Scholten DJ II, Timmer CM, Peacock JD,
Pelle DW, Williams BO and Steensma MR: Down regulation of Wnt
signaling mitigates hypoxia-induced chemoresistance in human
osteosarcoma cells. PLoS One. 9:e1114312014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Yang C, Gao R, Wang J, Yuan W, Wang C and
Zhou X: High-mobility group nucleosome-binding domain 5 increases
drug resistance in osteosarcoma through upregulating autophagy.
Tumour Biol. 35:6357–6363. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zhang CL, Wang C, Yan WJ, Gao R, Li YH and
Zhou XH: Knockdown of TNFAIP1 inhibits growth and induces apoptosis
in osteosarcoma cells through inhibition of the nuclear factor-κB
pathway. Oncol Rep. 32:1149–1155. 2014.PubMed/NCBI
|
|
30
|
Liang G, Xu E, Yang C, Zhang C, Sheng X
and Zhou X: Nucleosome-binding protein HMGN2 exhibits antitumor
activity in human SaO2 and U2-OS osteosarcoma cell lines. Oncol
Rep. 33:1300–1306. 2015.
|
|
31
|
He H, Jazdzewski K, Li W, Liyanarachchi S,
Nagy R, Volinia S, Calin GA, Liu CG, Franssila K, Suster S, et al:
The role of microRNA genes in papillary thyroid carcinoma. Proc
Natl Acad Sci USA. 102:19075–19080. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Patnaik SK, Kannisto E, Mallick R and
Yendamuri S: Overexpression of the lung cancer-prognostic miR-146b
microRNAs has a minimal and negative effect on the malignant
phenotype of A549 lung cancer cells. PLoS One. 6:e223792011.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Lin CH, Ji T, Chen CF and Hoang BH: Wnt
signaling in osteosar-coma. Adv Exp Med Biol. 804:33–45. 2014.
View Article : Google Scholar
|
|
34
|
Zhou Y, Lan J, Wang W, Shi Q, Lan Y, Cheng
Z and Guan H: ZNRF3 acts as a tumour suppressor by the Wnt
signalling pathway in human gastric adenocarcinoma. J Mol Histol.
44:555–563. 2013. View Article : Google Scholar : PubMed/NCBI
|
